Pharmacological Inhibition of Caspase and Calpain Proteases: A Novel Strategy to Enhance the Homing Responses of Cord Blood HSPCs during Expansion by V. M., Sangeetha et al.
Pharmacological Inhibition of Caspase and Calpain
Proteases: A Novel Strategy to Enhance the Homing
Responses of Cord Blood HSPCs during Expansion
Sangeetha V. M., Darshana Kadekar, Vaijayanti P. Kale, Lalita S. Limaye*
Stem Cell Biology Laboratory, National Centre for Cell Science, Ganeshkhind, Pune University Campus, Pune, Maharashtra, India
Abstract
Background: Expansion of hematopoietic stem/progenitor cells (HSPCs) is a well-known strategy employed to facilitate the
transplantation outcome. We have previously shown that the prevention of apoptosis by the inhibition of cysteine
proteases, caspase and calpain played an important role in the expansion and engraftment of cord blood (CB) derived
HSPCs. We hypothesize that these protease inhibitors might have maneuvered the adhesive and migratory properties of the
cells rendering them to be retained in the bone marrow for sustained engraftment. The current study was aimed to
investigate the mechanism of the homing responses of CB cells during expansion.
Methodology/Principal Findings: CB derived CD34
+ cells were expanded using a combination of growth factors with and
without Caspase inhibitor -zVADfmk or Calpain 1 inhibitor- zLLYfmk. The cells were analyzed for the expression of homing-
related molecules. In vitro adhesive/migratory interactions and actin polymerization dynamics of HSPCs were assessed. In
vivo homing assays were carried out in NOD/SCID mice to corroborate these observations. We observed that the presence
of zVADfmk or zLLYfmk (inhibitors) caused the functional up regulation of CXCR4, integrins, and adhesion molecules,
reflecting in a higher migration and adhesive interactions in vitro. The enhanced actin polymerization and the RhoGTPase
protein expression complemented these observations. Furthermore, in vivo experiments showed a significantly enhanced
homing to the bone marrow of NOD/SCID mice.
Conclusion/Significance: Our present study reveals another novel aspect of the regulation of caspase and calpain proteases
in the biology of HSPCs. The priming of the homing responses of the inhibitor-cultured HSPCs compared to the cytokine-
graft suggests that the modulation of these proteases may help in overcoming the major homing defects prevalent in the
expansion cultures thereby facilitating the manipulation of cells for transplant procedures.
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Introduction
Expansion of stem/progenitor cells from cord blood is an
important area of research in the field of clinical/experimental
hematology. Despite the recent advancements in this field,
investigations have shown that the expanded grafts exhibit altered
biological functions. Among the cellular changes, the important
functional impairment seen is the reduced/defective homing
ability of these cells in culture thereby hampering their
transplantation potential. Homing is an important prerequisite
for engraftment, which utilizes the ability of HSPCs to migrate,
adhere and lodge within the bone marrow niches and involve the
synergistic action of adhesion molecules and integrins [1–3].
Previous studies revealed that the defective homing observed in
cultured cells is due to the down regulation of beta integrins and
chemokine receptors especially CXCR4, which is an indispensible
homing molecule crucial for the trafficking of stem cells into the
bone marrow following intravenous infusion [4,5]. CXCR4 is
further implicated in the maintenance of HSC quiescence,
therefore the apparent down regulation may affect the HSC
maintenance as well as engraftment [6,7].Though a plethora of
contributing factors have been under scrutiny, the exact molecular
mechanism behind these altered features is still elusive.
The role of cell cycle, survival cues and that of integrin signaling
in altering the homing properties has been evaluated in earlier
studies [8,9]. Interestingly, the role of apoptosis in causing a
homing defect in the cultured HSPCs was also documented
[10,11]. Moreover, it was shown that 24 hours of cytokine
treatment is enough to predispose the HSPCs to apoptosis,
reducing their engraftment ability thereby linking apoptosis as a
factor that affects the cellular functions [12]. Previously, we
identified a distinctive aspect of apoptosis (negative regulation) that
influenced the expansion of CD34
+ cells. Our study revealed that
the cell-permeable inhibitors of caspase and calpain proteases,
augmented the expansion and long-term engraftment of cord
blood CD34
+ cells [13]. We speculated that the mechanism
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29383behind the sustained engraftment might lie in the ability of the
inhibitors to influence the migratory and adhesive interactions of
these cells in vitro.
To explore this aspect, we studied the homing responses of
cytokine-expanded HSPCs (Control) with those that were
additionally supplemented with the inhibitors, zVADfmk/
zLLYfmk. In agreement with our hypothesis, we noticed that
the presence of protease inhibitors in a cytokine-containing culture
system positively influenced the cell polarization, migratory and
adhesive responses and in vivo homing of expanded cells. The
current results together with our previous observations emphasize
the importance of the modulation of these proteases for generating
functionally superior HSPCs in an ex vivo system.
Results
HSPCs expanded in the presence of zVADfmk or zLLYfmk
showed a higher CXCR4 expression
CXCR4-SDF1 interaction is crucial for stem cell homing and
retention. Since CXCR4 expression is reportedly altered during
expansion, we analysed the expression of CXCR4 protein in our
optimized culture conditions. The expansion of CB-derived HSPCs
in the presence of zVADfmk/zLLYfmk resulted in a two-fold
increase in CXCR4 positive population (Figure 1A,* p#0.05,
**p#0.01,n=5).Arepresentativeflowcytometryprofileisshownin
inset (Figure 1A). Percent CXCR4 population ranged from
30%63.35, 60%62.54 and 61%63.89 in the control, zVADfmk
and zLLYfmk sets respectively. Images captured under confocal
microscope after immunostaining of the expanded cells also showed
a higher expression of CXCR4 on the HSPCs cultured in the
presence of inhibitors (zVADfmk/zLLYfmk) compared to the
control (Figure 1B). Since the CD34
+ cells expressing CXCR4 are
important for HSC functions, the expanded cells were further
assessed for the co-expression of these two markers. It was found
that the sets containing zVADfmk/zLLYfmk, retained a two-fold
higher number of CD34
+CXCR4
+ population compared to the
control. On an average CD34
+CXCR4
+ subsets ranged from
15.85%62.32 in control compared with the 29.85%63.87 in
zVADfmk and 29.05%63.9 in zLLYfmk containing cultures.





12.067%60.984 and 11.73%61.76 in control, zVADfmk and
zLLYfmk respectively) indicating the retention of primitive
progenitors to a higher extent in the cultures (Figure 1C,
* p#0.05, n=4, Figure S2A and S2B).
Migration towards Stromal Derived Factor 1-a (SDF1) was
enhanced in the zVADfmk/zLLYfmk HSPCs
Since the CXCR4 (putative receptor of chemokine SDF1a),
expression was up regulated; we next compared the chemotactic
responses of the control and zVADfmk/zLLYfmk HSPCs towards
SDF1a. We observed about a two- fold increase in the migration
ability of the HSPCs that were cultured with inhibitors (60%) as
compared to the control (30%) (Figure 2A,* p#0.05, **p#0.01,
n=4). Thus the data demonstrated that the higher CXCR4
expression in zVADfmk/zLLYfmk HSPCs was functional in
maintaining stronger chemotactic responses. We also observed
that the colony forming ability of migrated fraction of the
zVADfmk/zLLYfmk HSPCs were superior to that of control cells
when subjected to methyl cellulose based colony assays
(Figure 2C,* p#0.05, **p,0.01, n=3). The number of Burst
forming unit erythroid (BFU-E) ranged from 28.6665.5,
25.3365.03 and 3967.8 in control, zVADfmk and zLLYfmk
respectively. The Granulocye Macrophage (GM) colonies were
significantly increased in zVADfmk 250615.04 and in zLLYfmk
(295.6611.71) compared to control (150634.69) . There was also
an increase in the CFU GEMM (Granulocyte - Erythrocyte -
Macrophages and Megakaryocytes) colonies in the migrated
fraction of inhibitor cultured HSPCs (4.6662.88 in control vs
26.063.0 and 36.33612.055 in zVADfmk and zLLYfmk) relative
to the control (4.6662.88).
As a next step, we sought to confirm the specificity of CXCR4
mediated migration. Neutralizing antibodies for blocking the
surface CXCR4 on HSPCs was employed prior to migration. A
significant reduction in migration was observed in all the three sets
after CXCR4 blocking (Figure 2B, n=3). Since expanded cells
are more heterogeneous in nature and our previous results showed
that zVADfmk/zLLYfmk expands the functional CD34
+ cells, we
further examined whether treatment with these inhibitors afforded
a ‘priming’ effect on the immature CD34
+ cells.
To study this aspect, the isolated CD34
+ cells were incubated
overnight with cytokines in presence or absence of the protease
inhibitors and were then subjected to chemotaxis towards SDF1a.
We noticed an enhanced migration of CD34
+ cells, incubated with
zVADfmk/zLLYfmk compared to the control (Figure S2C,
**p,0.01, n=4). The percent migration was 5767.5, 82.2567.3
and 76.2566.2 in controls, zVADfmk and zLLYfmk respectively.
Interestingly, though there was improved migration in the test sets,
the CD34
+ cell number was found to be unaltered as assessed by
flow cytometry (.90%, as seen from Figure S2D). We further
observed that this increase in migration owed to a higher CXCR4
expression levels in these sets. The CXCR4 population ranged
from 11.0%60.913 in control, 17.750%61.708 in zVADfmk and
18.50%62.887 in zLLYfmk after overnight incubation. A
representative flow cytometry profile is shown in Figure S2E,
n=4). Furthermore, phenotypic analyses of the migrated fraction
revealed that there was higher percentage of CD34
+CD38
2 subset
in the treated set, suggesting the positive influence of these
inhibitors in ‘priming’ the homing responses of immature CD34
+
cells (Figure S2D, n=4).
Presence of zVADfmk/zLLYfmk during expansion
enhanced the expression profile of adhesion molecules
on the cultured HSPCs
The adhesion of HSPCs to endothelial wall/ECM proteins is
mediated by the synergistic action of selectins, cell adhesion
molecules (CAMs) and integrins. Flow cytometry analysis showed
a higher percentage of CD62L positive cells co-expressing CD34
marker in the inhibitor cultured HSPCs after expansion
(Figure 3A). We also observed that the total expanded HSPCs
from zVADfmk/zLLYfmk sets retained a higher percentage of
CD62L (L selectin) population (44.75%68.05 in zVADfmk and
43.75%65.6 in zLLYfmk) relative to the control cells
(27.25%62.2) (Figure S3 A,* p,0.05, n=6). Confocal imaging
showed that these cells also stained intensely for CD62L,
compared to the control (Figure S3B). While speculating a
logical reason behind this up regulation, we analyzed the
expression level of CD62L cleaving enzyme TACE (ADAM-17)
after expansion. Interestingly, we observed that the presence of
zVADfmk/zLLYfmk resulted in a simultaneous reduction in the
cells expressing TACE, which is a known sheddase of CD62L. The
TACE positive population ranged from 48%64.5 in control
compared to the 32.3%65.3 in zVADfmk and 31.5%64.8 in
zLLYfmk HSPCs (*p#0.05, n=4). A representative flow profile
from an experiment is shown in Figure S3C. The results
indicated that the inhibitors of caspase and calpain significantly
lowered the percentage of cells expressing TACE, pointing out to
the possibility of retention of CD62L upon higher survival cues.
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CD54 (Intercellular Cell Adhesion molecule-1/ICAM-1) and
CD44 (Hyaluronan Cell Adhesion molecule/HCAM) was also
found to be influenced in these culture conditions. A higher
number of CD34
+ cells in zVADfmk/zLLYfmk cultures co-
expressed CD54 and CD44 on their surface. CD34
+CD54
+ cells
ranged from 6.61%62.02 in control, 11.8%61.0 in zVADfmk
and 10.73%61.09 in zLLYfmk respectively. The cells co-
Figure 1. CXCR4 expression analysis of the cultured HSPCs. (A) The expanded cells were stained using anti CXCR4 antibody and the
expression was assessed by flow cytometry. HSPCs cultured in the presence of zVADfmk/zLLYfmk showed a two-fold increase in the CXCR4
+
population compared to the control counterpart. Data are represented as mean percentage 6 standard deviation of five biological replicates,
*p#0.05, **p#0.01. A representative flow-overlay is shown in the inset. (B) Confocal microscopy images further confirm higher expression of CXCR4
(green) on cell surface of HSPCs from zVADfmk/zLLYfmk cultures than that of controls. Cell nuclei (blue) were stained with DAPI (bar =10 mm, n=3).








2 hematopoietic progenitor cells. Data are represented as mean percentage 6 standard deviation of four experiments, *p#0.5.
doi:10.1371/journal.pone.0029383.g001
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PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29383expressing CD34 and CD44 ranged from 34%65.5 in control vs
44.6%64.4 and 48.3%63.05 in zVADfmk and zLLYfmk
respectively (n=3). Representative flow cytometry dot plot is
depicted in Figure 3B and 3C. We also checked whether the
presence of zVADfmk/zLLYfmk enhanced the adhesion molecule
profile on primitive cells within the expanded compartment by
carrying out multi color staining on expanded cells. As shown in
Figure 3D, the inhibitor treated HSPCs retained a higher
percentage of CD62L, CD44 and CD54 on CD34
+CD38
2
fraction of expanded cells compared to the control (*p#0.05,
**p#0.01, n=3). Immunostaining of the cells also showed a
higher protein density of these two CAMs on the cell surface of
zVADfmk/zLLYfmk HSPCs compared to the control (Figure
S3D, upper and lower panels n=3).
zVADfmk/zLLYfmk enhanced the expression of integrins
CD49d/VLA-4 and CD49e/VLA-5, potentiating the
adhesive interactions to fibronectin
The integrins CD49d and CD49e are important mediators in
the homing and engraftment of HSPCs. Given the improved
profile of adhesion molecules, we were curious to analyse whether
these caspase and calpain inhibitors affected the presence of major
integrins (CD49d/VLA-4 and CD49e/VLA5) on these cells.
Multicolor imunostaining followed by flow cytometry analysis
showed that zVADfmk/zLLYfmk HSPCs increased the percent-
age of integrins on CD34
+CD38
2 subset of the expanded pool







+ in control was 13%61.52 and
11%61.32. In zVADfmk the expression was 21.66%63.15 and
23.5%63.85 respectively. zLLYfmk showed 20.0%62.64 and
19.83%62.02 percentage of the primitive subset respectively.
However, we did not observe any significant change in the
percentage of cells expressing these integrins on total expanded
cells. The percentage of cells expressing CD49d and CD49e in
control was 85%65.0 and 77.66%62.517. In zVADfmk the
prescentage was 89%63.606 and 81.66%67.638, and in
zLLYfmk the same was 90%62.646 and 83%64.58 respectively.
In the meantime, we noticed that the inhibitor – cultured cells
showed a higher mean fluorescence intensity of these integrins
relative to the control as assessed from flow cytometry (Figure
S4A,* p,0.05, **p,0.01, n=4). Since integrin functions are
heavily dependent upon the affinity status rather than the
expression (inside-out signaling), we proceeded to map the
functional activity/affinity epitope of the b1 integrins using
HUTS21 mAb. We observed that the zVADfmk/zLLYfmk
HSPCs exhibited a higher expression of HUTS 21 compared to
the control pointing out to a functionally active conformation of
integrins on them (Figure S4B). When subjected for adherence
on ECM protein fibronectin, these cells showed a two-fold increase
in the adhesion assessed from the cell-matrix adhesion assay
(Figure 4B,* p,0.05, n=4). Since fibronectin mediated adhesion
activates the integrins and forms firm focal adhesions, we again
assessed the activity-epitope of integrins in the HSPCs that were
adhered to the fibronectin. As seen from Figure 4C, the adhered
HSPCs in the zVADfmk/zLLYfmk cultures exhibited its active
ligand binding status compared to the control cells. Furthermore,
these adhered cells showed an enhanced activation of Focal
adhesion kinase as detected using FAKpY397 immunostaining
(Figure 4D).
Effect of blocking of integrins and adhesion molecules
on the in vitro migration and adhesion of expanded
HSPCs
The enhancement in the integrin and adhesion molecule profile
after expansion was an important observation. We wanted to
investigate these differences with respect to the functional
significance of these molecules in the expanded cells. To explore
this part,in vitro migration to SDF1a and adhesion to ECM protein
fibronectin was carried out after a series of function blocking
experiments for CXCR4, CD49d, CD49e, CD44, CD62L and
CD54. We noticed that the trans-well chemotaxis of expanded
control and inhibitor treated HSPCs significantly reduced when
CXCR4 was blocked (as in accordance with the previous
observation in Figure 2). Neither the blocking of CD49d and
CD49e showed an effect in the trans-well assay, nor the adhesion
molecules, implying the dominance of CXCR4-SDF1 axis
(Figure 5A *p,0.05, **p,0.05, n=3). However, neutralizing
the integrins (CD49d & CD49e) and cell adhesion molecules
significantly reduced the adhesive interactions to fibronectin, even
though the effect of CD54 blocking was moderate (Figure 5B,
*p,0.05, **p,0.05, n=3).
Caspase and calpain inhibitors, positively modulated the
actin polymerization and enhanced the expression of
RhoGTPase members: RhoA, Rac1 and Cdc42
Cytoskeletal re-arrangements play an important role in the
adhesive and migratory interactions in various cell systems. To
explore this aspect in the expanded HSPCs, the polymerized actin
content of the control and zVADfmk/zLLYfmk sets were analyzed
separately after the 10
th day of culture. We found that the mean
intensity (MFI) of the fluorescein-conjugated phalloidin was
significantly higher in the test sets as quantified from flow
cytometry. The MFI ranged from 164096443 in control vs
247196685 in zVADfmk and 2633461210 in zLLYfmk respec-
tively (Figure 6A,* p#0.05, n=4). We then investigated the
extent and kinetics of actin polymerization in the cultured HSPCs
by exposing the cells to chemokine SDF1a for different time
periods. It was observed that at all time points analyzed; the mean
intensity of F actin was markedly higher in the zVADfmk/
zLLYfmk sets compared to the control. The kinetics revealed a
rapid increase in the actin polymerization at 40 sec after the SDF1
exposure in the test sets, which further peaked at 80 sec especially
in the zVADfmk HSPCs. In the mean time, the control cells
showed a delay in F actin formation and the extent of
polymerization peaked only after 160 sec of chemokine exposure.
This indicated that the observed advantage of the zVADFmk/
zLLYfmk HSPCs in the adhesion and migration may be
associated with a higher and early response to the chemokine
mediated F actin formation (Figure 6B,* p,0.05, n=3). In
parallel experiments, the F actin distribution was visualized in the
Figure 2. In vitro migration of expanded CB HSPCs. (A) The presence of zVADfmk/zLLYfmk during ex vivo expansion significantly increased the
chemotaxis of HSPCs towards SDF1a compared to the cytokine-expanded (control) counterpart. Data are represented as mean 6 standard deviation
of four experiments, *p#0.05, **p#0.01. (B) The migration of expanded HSPCs towards SDF1a was reduced when a neutralizing antibody to CXCR4
was used, indicating the direct role of CXCR4 in maintaining the chemotactic responses. Data are represented as mean 6 standard deviation of three
experiments. (C) The colony forming assay of the migrated population showed a higher clonogenicity, especially the presence of primitive
progenitors in terms of CFU mix/GEMM colonies in the zVADfmk/zLLYfmk cultures. Data obtained from three experiments are represented as mean 6
standard deviation, *p#0.05, **p,0.01.
doi:10.1371/journal.pone.0029383.g002
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shown in Figure 6C, Filamentous actin showed a homogenous
distribution in the migrated control HSPCs, where as the
zVADfmk/zLLYfmk HSPCs showed a notably more polarized
distribution of F actin, towards the leading edge of the cells
(Figure 6C, inset, a 36 magnified area) indicating a higher cell
polarization. Given the importance of RhoGTPase members in
actin remodeling and polymerization, our next step was to analyze
the status of Rho GTPase members after the ex vivo expansion.
Immunostaining and subsequent confocal imaging of Rho family
Figure 3. Higher expression of adhesion molecules in the expanded HSPCs. (A) & (B & C) Flow cytometry analyses of HSPCs after staining
for CD34 vs CD62L, CD34 vs CD54 and CD34 vs CD44 antibodies demonstrate higher positive population of these adhesion molecules on CD34
+
progenitor cells. (D) Alternatively multi colour flow cytometry analyses showed that zVADfmk/zLLYfmk enhanced the presence of CD62L, CD44 and
CD54 on CD34
+CD382 subsets as well. Data are represented as mean percentage 6 standard deviation of four experiments, *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0029383.g003
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expression of these proteins in the zVADfmk/zLLYfmk HSPCs
(Figure 6D, n=3). Rac1 transcripts showed a modest increase
compared to the control. However, there was around 3.2 fold and
2.5 fold increase in the RhoA (a transcipt abundance of 16
10
760.1610
7 in control vs 3.2610
760.2610
7 in zVADfmk and
3.1610
760.3610
7 in zLLYfmk) and Cdc42 transcript abundance
(1.3610
760.1610





7 in zLLYfmk respectively assessed by real
time PCR. These observations indicate a positive influence of
caspase and calpain inhibition on active actin remodeling
(Figure 6E,* p,0.05, **p,0.01, n=3).
In vivo homing of zVADfmk/zLLYfmk HSPCs was superior
to that of the cytokine cultured cells and was mediated
through the CXCR4 axis and integrins
Our previous studies showed that the zVADfmk/zLLYfmk
HSPCs were superior in forming a sustained long-term multi-
lineage engraftment in NOD/SCID mice. The observations so far
showed superior homing properties of HSPCs expanded in the
presence of caspase/calpain inhibitors. To validate our current in
vitro observations, we carried out an in vivo short-term homing
experiments in the NOD/SCID mouse model as illustrated in
Figure 7A. Equal numbers of expanded control and zVADfmk/
zLLYfmk cells were infused intravenously into sub-lethally
irradiated NOD/SCID mice. After 24 hours of transplantation,
the bone marrow and spleen cells were immunostained for human
specific CD45 and CD34 antibodies as described in methods. Flow
cytometry analyses showed a recovery of significantly higher
number of huCD45
+ cells from the bone marrow of animals that
received zVADfmk/zLLYfmk HSPCs. The percentage of
huCD45
+ cells in the bone marrow ranged from 1.08%60.174
in control animals compared to 2.24%60.175 and 2.4%60.324 in
animals that received inhibitor cultured HSPCs (Figure 7B,
**p#0.01, n=4 independent experiments). To analyze the donor
CD34
+ progenitor homing, the recovered marrow cells were also
stained using human specific CD34. We further observed a higher
number of human CD34
+ cells in the bone marrow of the
irradiated recipient that received the zVADfmk/zLLYfmk HSPCs
relative to the control. The range of huCD34
+ progenitors
recovered was 0.82%60.146 in control, 1.62%60.322 in
zVADfmk and 1.84%60.36 in zLLYfmk respectively
(Figure 7B,* p#0.05, **p,0.01 n=5 independent experiments).
Similarly the presence of donor CD45
+ cells in the spleen of the
animals that received zVADfmk/zLLYfmk HSPCs were also
higher. However, we noticed that the homing of CD34
+
progenitors to the spleen was low and was unaffected by the
presence of inhibitors. (huCD45
+ and huCD34
+ cells in spleen
ranged from 0.76%60.181 and 0.54%60.234 in control com-
pared to 1.44%61.93 and 0.8%60.36 in zVADfmk and
1.08%62.3 and 0.6%60.32 in zLLYfmk) Representative flow
cytometry profiles are shown in Figure S5A–S5B. The CFC
recovery of the human cells from the bone marrow was
significantly higher in the animals those received zVADfmk/
zLLYfmk cultures confirming the above observations (5.263.4, in
control to that of 16.365.1 and 11.561.5 in zVADfmk and
zLLYfmk, Figure S5C,* p,0.05, n=3). These observations thus
clearly indicated that, the presence of caspase and calpain
inhibitors augmented the in vitro homing responses of the expanded
Figure 4. Improved expression of CD49d and CD49e integrins and higher adhesion of the expanded HSPCS. (A) Multicolour flow
cytometry analysis showed a an increase of CD49d and Cd49e integrins in the primitive CD34
+CD38
2 fraction of inhibitor-treated HSPCs. Data are
represented as mean percentage 6 standard deviation of four experiments, *p,0.05. (B) Adhesion to extracellular matrix protein fibronectin was
significantly increased (up to two fold) in the zVADfmk/zLLyfmk cultures compared to the control. Data are represented as mean 6 standard
deviation of four experiments, *p,0.05. (C) The adhered zVADfmk/zLLYfmk HSPCs retained a higher b1 integrin ligand binding status and the
activation of focal adhesion kinase (D) compared to the control, green- HUTS 21, red – FAKpY397, blue – nuclei, scale 10 mm.
doi:10.1371/journal.pone.0029383.g004
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paving an ideal situation for sustained engraftment.
To further assess the effect of the CXCR4-SDF1 axis, integrins
and adhesion molecules in short-term homing ability of expanded
HSPCs in vivo, we used blocking antibodies for the above markers
to block surface receptors prior to homing assay. After 24 hours of
transplantation, the bone marrow and spleen cells were analysed
for the presence of human cell population by staining using
antihumanCD45 antibody. We observed that blocking of CXCR4
and integrins had a profound negative effect in the homing of
HSPCs to the bone marrow and spleen of irradiated recipient
compared to the respective unblocked sets (Figure 7C–7D,
*p,0.05, *p,0.05, n=3 independent experiments). The inhibitor
expanded cells indeed showed an increase in homing compared to
control in these conditions. However, we did not observe any
significant reduction in the homing responses of HSPCs to bone
marrow and spleen when blocking antibodies for CD44, CD62L
and CD54 was employed. (Figure S6A–S6B).
Figure 5. Effect of blocking of integrins and adhesion molecules on the migratory and adhesive properties. (A) In vitro migration of
expanded control and inhibitor-treated HSPCs to SDF1 was not affected by blocking of the integrins alone. Data are represented as mean 6 standard
deviation of three experiments, *p,0.05, **p,0.01, ***p,0.01. (B) However, the blocking of integrins and adhesion molecules reduced the in vitro
adhesive interaction of expanded HSPCs to a higher extent. Data are represented as mean 6 standard deviation of three experiments, *p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0029383.g005
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29383Figure 6. Actin dynamics of expanded HSPCs. (A) The expanded control and zVADfmk/zLLYfmk HSPCs were assessed for the polymerized actin
(F actin) using fluorescein conjugated phalloidin. The presence of zVADfmk and zLLYfmk enhanced the of F actin fluorescence intensity compared to
the control. Data are represented as mean 6 standard deviation of four experiments, *p#0.05. (B) Actin polymerization assay done by exposing the
control and test HSPCs to SDF1a for different time intervals showed an early response and higher polymerization of actin at all time points analyzed
in the zVADfmk/zLLYfmk sets. Data are represented as mean 6 standard deviation of three experiments. Statistical analysis was always made
between control vs. zVADfmk/zLLYfmk at all time points. *p#0.05, **p,0.01. (C) The migrated population from the zVADfmk/zLLYfmk HSPCs showed
a typical polarized morphology with a prominent localization of F actin towards the leading edge of the cells (white arrow heads & insets) where as in
control cells a homogeneous distribution of F actin was seen without much visible cell polarization, green – F actin, bar=10 mm. (D) The expression
Improved Homing of Expanded HSPCs
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Expansion of the hematopoietic stem/progenitor cells (HSPCs)
are attempted worldwide to increase the number of HSCs and
HPCs for transplantation purposes. The feasibility of this method
has been demonstrated [14–16] but the major impediment
observed was the apparent change in the functions of the cultured
HSPCs. The biological or physiological changes occurring to these
cells in vitro, result in an ‘altered behavior’ explained by the loss of
‘stemness’, increased susceptibility towards apoptosis, defective
homing and engraftment [17]. Earlier study by Traycoff et al
showed that the proliferation-induced decline of primitive HSPC
activity was coupled with an increase in apoptosis in the expanded
CD34
+ cells [18]. Of note various investigators have shown a
possible role of apoptosis cascade in the regulation of stem cell
numbers [19–21]. Our belief regarding the role of apoptotic
proteases was rooted in our previous observation showing the
effect of caspase inhibitor; zVADfmk and calpian1 inhibitor;
zLLYfmk in expansion protocols (in the enhancement of CD34
+
cell content and multilineage engraftment of expanded HSPCs).
In the present study, we demonstrate another unique aspect of
this inhibition in boosting the in vitro and in vivo homing functions
of RhoGTPase members RhoA, Rac1 and Cdc42 was found to be increased in the zVADfmk/zLLYfmk HSPCs, green –RhoA, Rac1 and Cdc42,
bar=10 mm (E) Quantitative real time PCR analysis showing a significant up regulation in the gene expression of RhoA upto (3.2 fold) and Cdc42 (up
to 2.5 fold) in the zVADfmk/zLLYfmk expanded HSPCs compared to the control, whereas the Rac1 showed a modest increase in those sets. Data are
represented as mean 6 standard deviation of three experiments, *p#0.05, **p,0.01.
doi:10.1371/journal.pone.0029383.g006
Figure 7. In vivo homing expanded HSPCs. (A) Schematic illustration of the in vivo homing assay conducted in NOD/SCID mice. (B) After
24 hours of transplantation, the control and test animals were sacrificed and the bone marrow and spleen cells were assessed for the presence of
human CD45 and human CD34 markers. The animals that received the HSPCs expanded in the presence of either of the inhibitors exhibited a
significantly increased migration to the bone marrow and spleen tissues. Data are represented as mean 6 standard deviation of four experiments,
*p#0.05, **p,0.01. However, the CD34
+ cell homing to the spleen tissues were found to be unaffected. (C & D) Blocking of CXCR4 and integrins prior
to transplantation significantly reduced the bone marrow and spleen homing of expanded HSPCs compared to the unblocked respective sets. The
zVADfmk/zLLYfmk HSPCs showed an increase in homing compared to control (*p#0.05, **p,0.01, n=3 independent experiments).
doi:10.1371/journal.pone.0029383.g007
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CXCR4, upon protease inhibition followed by enhanced migra-
tion was an important one, as several studies have shown
engraftment defects owing to reduced CXCR4 functions [6,22].
The presence of higher number of multipotent progenitors
(GEMM) colonies in the migrated fraction of zVADfmk/zLLYfmk
HSPCs indicated an enrichment of primitive progenitors. To
exclude the possibility that the observed differences in the
migration are not merely due to the differences in the progenitor
content after culture, we checked the effect of short-term
incubation of these inhibitors on isolated CD34
+ cells. We
observed an enhancement in the migration of primitive
CD34
+CD38
2 in the zVADfmk/zLLYfmk ‘‘primed’’ CD34
+ cells
compared to the cytokine exposed counterpart. This observation
was interesting and set forth the notion that the inhibition of these
proteases may have a broader implication than expected.
Moreover, it was proved from the flow data that this enhanced
migratory effect was prominent on the long term engrafting
CD34
+CD38
2 subset. It would be noteworthy to mention that we
also observed a general reduction in the migration efficiency of
control cells (from 60% after short-term incubation to 30% after
10
th day of culture) compared to the zVADfmk/zLLYfmk HSPCs
(75% vs. 60% respectively) clearly pointing out to the functional
impairment of cytokine-cultured cells during ex vivo expansion.
The mechanisms of homing have revealed a host of contributing
factors including integrins and selectins, CD44, complement
proteins, certain lipid mediators, and intracellular signaling
molecules [23–25]. Our observation of higher numbers of
CD34
+ CD62L
+ cells after expansion was crucial as these
populations are reportedly important predictors of the transplant
outcome [26]. Surprisingly, we also noticed a lower percentage of
HSPCs expressing ADAM-17/TACE (CD62L cleaving enzyme)
in the zVADfmk/zLLYfmk sets. Various reports supported this
notion that TACE activity can be induced upon cellular apoptosis
through intrinsic and extrinsic pathways followed by CD62L
shedding [27,28]. It can also be contemplated that the reduced
apoptosis levels in the inhibitor expanded cells might have helped
in higher CD62L retention on them. However, the exact
specificity of TACE needs to be further verified to make a
conclusive statement. We did observe a reduction in the adhesion
of HSPCs in vitro when a neutralizing antibody to CD62L was
used. However, the blocking of CD62L was found to have no
effect on trans-well migration of expanded cells to SDF1 a. In the
in vivo scenario as well, homing to bone marrow was least affected
by the blocking of CD62L, whereas a moderate reduction was
seen in spleen homing. The role of HCAM1/CD44 is undoubt-
edly established in the homing of HSPCs as several groups have
shown the interaction of CD44 and lodgment of HSCs in the BM
[29,30]. Whether the higher CD44 protein density on the inhibitor
expanded HSPCs correlate with a higher fucosylation/glycation
status is an aspect that require further studies as this mechanism
was found to be important for its functionality [31]. Similar to the
above observation, blocking of CD44 was also not sufficient to
reduce the bone marrow homing, (correlating with the in vitro
migration after CD44 blocking) even though it did reduce in vitro
adhesion of HSPCs. Here we cannot exclude the possibility of not
properly spanning the functional epitopes of CD44/CD62L as
glycation/sialyl groups are indispensable for the functional
activation of CD44/CD62L [32].
Besides CD44 and CD54, we also observed a higher expression
of vinculin (data not shown) which is known to play a prominent
role in the anchoring of F actin to the membrane. Recently an
indispensable role of vinculin in HSPCs engraftment has also been
reported opening up the multifaceted functions of adhesion
molecules in HSC biology [33]. The reduced adhesion receptor
expression and functional binding of integrins to matrix proteins
was also discussed as the molecular basis of defective homing [34].
Moreover, a recent study documented the negative aspect of
calpain proteases in focal adhesion dynamics and migration [35].
We show that the presence of caspase/calpain inhibitors
positively influence the functional conformation of b1 integrins
without affecting the percentage of cells in total HSPCs expressing
them (inside-out signaling) thereby augmenting the adhesive
interactions to the ECM protein fibronectin. Since focal adhesions
are the integrin-mediated contacts between the cytoskeleton and
ECM, the integrin activation induces FAK to autophosphorylate
on Tyr-397. We observed a similar scenario on the adhered
zVADfmk/zLLYfmk HSPCs as they showed a higher expression
of pFAKy397 indicative of the activated state of focal adhesion
kinases usually observed when it is bound to b1 integrins. We
observed that the neutralizing antibodies to CD49d and Cd49e
significantly reduced the adhesion of HSPCs to fibronectin in vitro.
Interestingly, we did not observe any added effect of combined
blocking of integrins on in vitro adhesion (data not shown).
Surprisingly the trans-well migration to SDF1 in vitro was also not
affected unless the integrins were blocked together with CXCR4
(data not shown). This clearly indicated that the observation of
reduced migration was solely attributed to the blockade of
CXCR4. This may also be explained by the lack of a trans-
endothelial barrier in our in vitro experiments that can transduce
integrin-mediated signaling for migration. We presume that in
such a situation the, CXCR4-SDF1 axis gains dominance
independent of integrins to induce migratory responses in vitro.
Prior to migration, cells display a complex repertoire of motility-
associated processes, including shape changes, polarization, actin
polymerization, and polarized adhesion [36,37]. It has been
reported that chemokine-induced induction of actin polymeriza-
tion is most pronounced within the first 1 to 2 minutes after
stimulation of the receptor and is also superior in CB HSCs
compared to the PB derived HSCs. We observed a consistent
polymerization of cortical actin till 160 sec post SDF1a exposure
in accordance with the published reports [38,39]. However,
comparing the control and treated HSPCs, we infer that the
cytokine culture alone (control) delayed the cell polarization and
motility of HSPCs in response to chemokine signaling, adding to
another reason for their reduced migration. We reasoned that
enhanced F-actin polymerization in the expanded CB cells may
owe to the differences in the expression of signaling components
leading to RhoGTPase activation. The higher expression of
RhoA, Rac1 and Cdc42 in the zVADfmk/zLLYfmk HSPCs
indicated the possibility of involvement of these components as
well. RhoA, Rac1 and Cdc42 are found to act synergistically to
enhance the actin polymerization and homing interactions in
HSPCs, even though diverse functions are assigned to them in
various systems [40,41]. Higher Cdc42 expression is also
implicated in HSC self-renewal and quiescence as the studies
employing conditional knock down of Cdc42 in murine model
showed defects in maintaining HSC quiescence and retention in
the bone marrow [42].
Attempts to enhance the homing and engraftment of trans-
planted cells are in the forefront of investigations mainly because
not all HSPCs home efficiently. Studies including small molecule
agonists, prostaglandin E2, and the inhibition of dipeptidyl
peptidase IV (CD26) have been reported to enhance the homing
of both murine and human HSCs [43–45]. The fact of impaired
homing exhibited by cytokine-activated cells in NOD/SCID mice
was previously reported [10,11]. Other studies also demonstrated
that the homing of the HSPCs was followed by a phase of
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only when they reach BM [46]. However, several contradictory
reports exist regarding the proliferation of cells after immediate
transplantation/homing [47–49]. Since our major aim being the
comparison of homing efficiency of cytokine cultured vs.
zVADfmk/zLLYfmk cells, we did not address this particular
aspect in the current study.
Nonetheless, the immunostaining of recovered cells from the
recipient mice using human CD45 and CD34 markers revealed
that the presence of zVADfmk/zLLYfmk during expansion
significantly enhanced trafficking of HSPCs to the bone marrow
and spleen compared to the control. These results implied an ideal
scenario for sustained engraftment. Our in vivo homing assay
further showed that the enhanced homing of zVADfmk/zLLYfmk
HSPCs was importantly mediated through CXCR4-integrin axis.
We noticed that the bone marrow and spleen homing of expanded
HSPCs was significantly reduced when blocking antibodies for
either CXCR4 or integrins (CD49d & CD49e) were used. The
blocking of CD44, CD62L and CD54 did not affect the BM
homing, though a mild reduction was seen in spleen homing that
lacked significance to assign an importance. The differences in the
observation revealed by the blocking of adhesion molecules in an
in vitro cell-ECM adhesion system and in vivo homing may be
explained by the fact that ‘‘homing’’ involves adhesion as well as
migration of which latter is more important for BM lodgment.
This is also supported by the fact that homing and engraftment is
dependent on a threshold level of functional integrins and not
merely on the adhesion molecule expression. However, a
comparison of the effect of blocking of the above factors on
freshly isolated vs expanded HSPCs will further strengthen our
understanding on any differential effect of the adhesion molecules
in these two experimental conditions.
Nonetheless, through this study, we demonstrate a hitherto
unknown aspect of the regulation of apoptotic proteases in
augmenting the adhesive and migratory interactions of cultured
HSPCs through up regulation of functional integrins and CXCR4.
Thus the mechanism of the augmented in vivo homing by
zVADfmk/zLLYfmk may be partly mediated through the
CXCR4-SDF1 and integrin axis. The study further suggests that
the use of zVADfmk/zLLYfmk in combination with cytokines can
be envisioned as a promising approach to enhance the homing
potential of the HSPCs. The outcome of this study may also
complement the existing protocols for expansion and transplan-
tation of stem/progenitor cells.
Methods
Collection of Umbilical cord blood and isolation of CD34
+
cells
Cord blood samples were obtained after full-term deliveries and
collected from local hospitals with written informed consent of the
mother. The institutional review board committee named
Institutional ethical committee, National Centre for Cell Science
(IEC, NCCS) specifically approved this study. From cord blood,
mononuclear cells were separated using ficoll hypaque (density
1.077 g/ml, Sigma Aldrich, St.Louis MO) density gradient
centrifugation. CD34
+ cells were isolated from the mononuclear
cells using Dynal beads as per manufacturer’s instructions
(Dynabeads M-450 CD34; Dynal, ASA, Oslo, Norway).
Expansion of CD34
+ cells in serum free medium
Isolated CD34
+ cells were seeded at a density of 5610
4cells per
500 ml of Stempro medium (GIBCO, Grand Island, NY), in 24-
well tissue culture plates (Falcon, Beckton Dickinson, San Jose,
CA). Growth factors used were IL-6, SCF, TPO, and Flt-3-L
(Peprotech Inc, Rocky Hill, NJ) at a final concentration of 25 ng/
ml with (test cells) and without (control cells) the addition of either
zVADfmk 2100 nM or zLLYfmk 210 mM (MP Biomedicals,
Aurora, Ohio). After the 10
th day of culture, the cells were
collected from the suspension culture, and centrifuged (1000 rpm
for 5 minutes). The cells were used for assessing the in vitro homing
properties or were used for in vivo homing studies in NOD/SCID
mice.
Flow cytometry analysis
HSPCs were analyzed for the expression of CXCR4, CD34,
CD38, CD62L/L-selectin, CD49d/VLA-4, CD49e/VLA-5,
CD54, CD44 (all antibodies from BD pharmingen- San Jose,
California) and ADAM-17/TACE (R&D systems, Minneapolis,
USA). The expanded HSPCs were collected, washed and
suspended in 16phosphate buffer saline (PBS) containing 0.1%
bovine serum albumin (BSA). After the addition of antibodies, the
cells were incubated for 40 min on ice, washed using 16PBS and
were acquired on FACS. Appropriate isotype controls were kept
for each set. Total cells in the Forward Scatter (FSC) and Side
Scatter (SSC) pattern were gated after excluding the debris. A
minimum of 10,000 events for each sample was acquired on
FACS CantoII (Beckon Dickinson San Jose California) and
analyzed using FACS Diva software (Beckon Dickinson San Jose
California).
Immunofluorescence and Confocal microscopy
The expression of CXCR4, CD44, CD54, HUTS 21,
FAKpY397 (BD Pharmingen, San Jose, California), RhoA, Rac1
and Cdc42 (Santacruz biotech, Santacruz, CA, USA) were
analyzed. All primary antibodies were used at 1:50 dilutions.
Goat anti mouse monoclonal IgG FITC (BD pharmingen, San
Jose, California) and donkey anti mouse Cy3 (Chemicon
Internationals Billerica, MA 01821 USA) were used at 1:100
dilution. For staining, the cells were fixed in 4% paraformalde-
hyde, permeabilized using chilled 50% methanol (as per
requirement) and blocked with PBS containing 1% BSA for
1 hour. For visualizing the F actin by phalloidin staining, the cells
were permeabilized using 0.1% Triton X 100. Cells were
incubated overnight at 4uC with primary antibodies, washed with
PBS and then incubated with the respective secondary antibodies
along with DAPI (1 mg) at room temperature for 1 hour. Slides
were washed three times using 16 PBS and mounted using
mounting medium. For staining of the cells adhered to fibronectin,
adhesion assay was carried out in chamber slides (Thermo Fischer)
and the adhered cells were fixed in 4% paraformaldehyde followed
by immunostaining as described above. Confocal images were
obtained using a Zeiss LSM 510 Meta laser-scanning microscope.
Results presented are representative fields confirmed from a
minimum of three different biological samples.
RNA isolation and Real-time PCR analysis
Total RNA was isolated using Trizol reagent (Sigma Aldrich, St
Loius MO) as per manufacturer’s instructions. After extraction the
quantitation of RNA was done using nanodrop spectrophotometer
(ND1000). A ‘high capacity cDNA archive kit’ (Applied Biosys-
tems, Foster City, CA) was employed to carry out the first strand
cDNA synthesis using random hexamers. 1 mg RNA of each
sample was reverse transcribed to cDNA in 10 ml of final volume.
The real time PCR was performed using the Power SYBR-Green
master mix (Applied Biosystems, Foster City, CA) and specific
gene primers in a 7500 ABI-prism sequence detection system
(Applied Biosystems). The final reaction volume was 20 ml for each
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10 min, (95uC for 15 sec, 60uC for 1 min) for 40 cycles. Samples
without reverse transcription were used as negative controls. All
qRT-PCR values were normalized to 18s and calculated
according to the manufacturer’s instructions. The primer
sequences used are listed in Figure S1.
Trans-well migration assay
Chemotactic responses of the expanded control and test HSPCs
to stromal derived factor 1 (SDF1a) were assessed in vitro by trans-
well migration assay. Briefly, 10
5 of expanded cells were seeded
into the upper chamber of the 8 m insert. 100 ng of SDF1a was
added to the lower wells containing 600 mlof medium. For each
experimental set, some wells were kept without SDF1a to detect
the spontaneous migration. The cells were allowed to migrate for
5 hours at 37uC. The migrated cells were collected, manually
counted and subjected to colony formation assays. To check the
effect of these inhibitors on CD34
+ cells per se, freshly isolated
CD34
+ cells were incubated overnight with growth factors in the
presence or absence of zVADfmk/zLLYfmk. The CD34
+ cells
were then collected washed to remove the medium and was
analyzed for CD34, CD38 and CXCR4. The cells were then
subjected to migration experiment as described above. In parallel
experiments, the migratory responses of expanded cells were
studied after blocking of CXCR4, CD49d, CD49e, CD44, CD62L
and CD54 receptors employing neutralizing antibodies.
Colony Forming Unit assay
The expanded HSPCs those migrated to SDF1a were subjected
to clonogenic assays as described [50]. After 14 days of culture,
colony forming unit of Granulocytes-Macrophages (CFU-GM),
Burst Forming Unit Erythroids (BFU-E), and mixed colonies of
Granulocyte- Erythroid-Macrophage- Megakaryocytes (GEMM)
were scored under an inverted microscope. Colony assay of
NOD/SCID BM cells were also carried out to detect the human
CFC recovery. The mouse bone marrow cells (2610
6) were kept
for adherence (1 hr, 37uC, 5% CO2) to remove the stromal cells
and the non – adherent fraction was collected (approximately 10
6
cells) and subjected to CFU assay using human specific growth
factors and the colonies were scored after 2 weeks.
Cell – matrix adhesion assay
Adhesion of the expanded HSPCs to fibronectin was carried out
as per Miao et al [51]. Briefly 10
5 each of expanded control and
test HSPCs were seeded on fibronectin-coated plates which were
previously blocked using 1% BSA (37uC, 1 hour) to reduce the
non – specific binding. The plates were incubated for 35 minutes
(37uC, 5% CO2). The loosely adhered cells were gently washed off
and the adhered cells were fixed using 4% paraformaldehyde
(10 min, room temperature) and then stained using crystal violet
stain (0.1% in 70% methanol). The plates were washed three times
using sterile distilled water to remove the excess stain and were
then permeabilized using 0.1% Triton X 100 for 30 minutes, at
room temperature. The optical density (OD at 550 nm) was read
using an ELISA reader. The higher OD corresponded to a higher
adhesion. In parallel experiments the adhesion of expanded
HSPCs were studied after blocking of CD49d, CD49e, CD44,
CD62L and CD54 receptors employing neutralizing antibodies.
Actin polymerization assay
The extent of actin polymerization was studied in the expanded
cells. The expanded control and test HSPCs were exposed to
100 ng of SDF1a for different time points starting from 10–
320 sec. After each time point, the cells were washed, fixed,
permeabilized and transferred to a solution containing 1 U/ml
fluorescein conjugated phalloidin and incubated for 30 minutes,
followed by flow cytometry analysis.
In vivo homing assay in NOD/SCID mice
After the expansion period, equal number (1610
6) of control
and zVADfmk/zLLYfmk HSPCs were intra-venously infused to
sub-lethally irradiated (300rads) NOD/SCID mice (5–6 weeks
old). The study was conducted adhering to the institution’s
guidelines for animal husbandry and has been approved by the
Institutional animal ethical committee named as National Centre
for Cell Science Animal Ethical Committee(NCCS-AEC) –
National Centre for Cell Science/Committee for Purpose of
Control and Supervision of Experiments on Animals (NCCS –
CPCSEA). Approval number of the study was: -Institutional
Animal Care and Use Committee, Experimental Animal Facility -
IACUC EAF/2004/B-71. Mice were housed in sterilized cages
and received autoclaved food and water ad libitum. After 24 hours
of transplantation, the animals were sacrificed and the spleen, tibia
and femurs were collected. The cell suspensions from bone
marrow, and spleen were blocked using mouse CD16/32 (mouse
Fc blocker) and with human serum to eliminate non-specific
binding. The cells were then stained using human specific CD45
and CD34 and acquired on FACS to assess the pan hematopoietic
and donor progenitor cell homing respectively. Irradiated PBS
(vehicle) - infused animals were kept to detect the background
staining if any. In some experiments the expanded HSPCs were
blocked using neutralizing antibodies for CXCR4, integrins and
cell adhesion molecules prior to transplantation. The cells were
analyzed by flow cytometry and a minimum of 100000 events
acquired for each set.
Statistical Analyses
The statistical differences between groups were analyzed by
One-Way repeated measure analysis of variance using the software
SIGMA STAT (Jandel Scientific Corporation, San Rafael, CA) for
all the experiments. All comparisons were between control vs.
zVADfmk and control vs. zLLYfmk. The values were plotted as
mean 6 standard deviation. Probability value: *p#0.05,
**p#0.01, & ***p#0.001 were considered statistically significant.
Supporting Information
Figure S1 Table summarizes the list of primer sequenc-
es used for qRT-PCR studies.
(TIF)
Figure S2 Higher number of primitive subset in the
zVADfmk/zLLYfmk HSPCs. and the ‘priming’ effect of
the inhibitors on immature CD34
+ cells. (A) Representative
flow profile depicting a higher percentage of CD34
+CXCR4
+
subset in the zVADfmk/zLLYfmk HSPCs. (B) Three color flow




2 subset in the zVADfmk/ZLLYfmk
expanded HSPCs. Representative flow cytometry profile showing
CXCR4 vs. CD38 within the gated CD34 compartment (n=3),
(C) Over night treatment of isolated CD34
+ cells with cytokines
and zVADfmk/zLLYfmk resulted in an enhanced migration
compared to the control. Data obtained from four experiments are
represented as mean 6 standard deviation, **p,0.01, n=4. (D)
Short-term treatment of CD34
+ cells to zVADfmk/zLLYfmk did
not alter the CD34
+ population, but caused an improved
migration of primitive CD34
+CD38
2 subsets compared to the
control. A representative flow cytometry profile is shown (n=4).
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the CXCR4
+ population when the CD34
+ cells were incubated
with either zVADfmk or zLLYfmk compared to the control, n=4.
(TIF)
Figure S3 Higher expression of adhesion molecules on
the total HSPCs. (A) The zVADfmk/zLLYfmk HSPCs showed
the presence of higher percentage of cells expressing CD62L on
the surface. Data are represented as mean 6 standard deviation of
six experiments, *p,0.05. (B) The CD62L expression intensity
found to be higher in the zVADfmk/zLLYfmk sets inferred from
the immunostaining. Images were captured with confocal
microscope. CD62L-green, nuclei-blue, bar=10 mm. (C) Flow
cytometry analysis showed a significant reduction in the CD62L
cleaving enzyme TACE in the zVADfmk/zLLYfmk HSPCs
compared to the control. (D) Expanded control and test HSPCs
were immunostained against CD54 (ICAM-1) and CD44(HCAM)
and images were captured by confocal microscopy. The presence
of zVADfmk/zLLYfmk increased the expression of ICAM 1 and
HCAM1 compared to the control, red- CD54 and green - CD44,
blue – nuclei, bar=10 mm.
(TIF)
Figure S4 Higher expression of integrins CD49d and
CD49e on total expanded HSPCs. (A) Though the percentage
of cells expressing the major integrins did not vary between control
and inhibitor cultured HSPCs, the mean intensity of the integrins
CD49d/VLA-4 and CD49e/VLA-5 were seen to be enhanced in
the zVADfmk/zLLYfmk HSPCs. Data are represented as mean 6
standard deviation of four experiments, *p,0.05, **p,0.01 (B)
The expanded zVADfmk/zLLYfmk HSPCs showed a higher
functional expression of b1 integrin epitope as assessed from
HUTS 21 immunostaining after expansion. HUTS21-Green,
nuclei-blue, scale bar 10 mm.
(TIF)
Figure S5 Improved in vivo homing potential of
zVADfmk/zLLYfmk HSPCs. (A)Representative flow profile
showing a higher number of human CD45 and huCD34
population within the bone marrow compartment of recipient
mice (B) Representative flow profile showing a higher homing of
human CD45
+ cells to the spleen tissues of the recipient mice.
However, the CD34
+ progenitor cell homing to spleen was low
and showed no marked difference between the control and test
animals. (C) The human CFC recovery from the femurs and tibias
of the NOD/SCID mice showed that the animals that received the
zVADfmk/zLLYfmk HSPCs showed a higher CFC recovery in
the presence of human growth factors confirming the observation
of higher homing to bone marrow. Data are the mean 6 standard
deviation of three experiments, *p#0.05.
(TIF)
Figure S6 Effect of blocking of adhesion molecules on
the in vivo homing of control and inhibitor-cultured
HSPCs. (A&B) The expanded HSPCs were blocked for CD44,
CD62L, and CD54 prior to transplantation and the human cell
homing was detected after 24 hours using huCD45 marker. There
was no change in the homing efficiency of unblocked vs adhesion
molecules blocked sets in the BM homing. A moderate reduction
in spleen homing was observed (Figure S6B) but was not
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